Trending
- 48 Hours of High Fever, No Treatment, and a Near-Death Health Scare
- Watch, but do not wait: On the Ebola outbreak
- Sanofi’s Rare Lung Disease Drug Outperforms Standard Therapy in Head-to-Head Trial
- Here are our favorite Memorial Day tech deals so far
- Elon Musk said Sam Altman “stole” a non-profit — but the trial showed he had similar aims
- Ind-Ra says West Asia tensions, El Nino to drag FY27 growth to 6.7%
- Mankind Pharma profit jumps 30% on chronic therapy demand in Q4
- What’s going on in sustainable fashion? How lower prices trumped principles.